Sivu 1 alkaen 106 tuloksia
TECHNICAL FIELD AND BACKGROUND ART
The present invention relates to administration of a toxic agent to a subject with cancer, in a formulation in which toxicity is substantially reduced and/or therapeutic efficacy enhanced. The most widely used methods to treat cancer are surgery, radiation and
FIELD OF THE INVENTION
The present invention relates to crosslinked collagen-polysaccharide matrices for the treatment of bone tumors and methods of treatment using the matrices. The present invention provides a crosslinked collagen-polysaccharide matrix that is administered together with a
FIELD OF THE INVENTION
The present invention relates to the technical field of polysaccharide, specifically relating to the use of a Cistanche deserticola polysaccharide in the preparation of functional food having efficacy of inhibiting colon cancer.
BACKGROUND OF THE INVENTION
Researches of
TECHNICAL FIELD OF THE INVENTION
This invention relates to the field of cancer vaccines. In particular, the application relates to carbohydrate-based immunogenic compositions containing fucose-enriched polysaccharides isolated from a fucose-containing extract of Ganoderma lucidum. More particularly,
TECHNICAL FIELD
The present invention relates to the rapid preparation of functionalized nano-selenium, and more particularly, to a Pleurotus tuber-regium polysaccharide functionalized nano-selenium hydrosol with anti-tumor activity and a preparation method thereof.
BACKGROUND ART
Selenium is one of
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a drug carrier comprising a novel polysaccharide and a drug complex. More particularly, the present invention relates to a drug carrier comprising a polysaccharide combined with a peptide, and a drug complex
FIELD OF INVENTION
The field of this invention is therapeutic agents and methods of treating tumors.
BACKGROUND OF INVENTION
Group .beta.-hemolytic Streptococcus (GBS) are ubiquitous microorganisms. GBS is not known to cause any harmful infections in humans except for very young babies. GBS
The present invention relates to aerosol compositions containing a carrier agent capable agent capable of recognizing and binding to inflammatory and tumor foci mobilizing macrophages in their immediate environment, and an aerosol substrate.
More especially, the present invention relates to aerosol
The invention relates to an agent and a product containing the agent for the diagnosis and treatment of malignant tumors as well as for the treatment of weaknesses in the cellular and humoral immune defense.
The diagnosis and treatment of malignant tumors is still difficult today despite intensive
BACKGROUND OF THE INVENTION
Tumor-specific antigens have been identified and pursued as targets for vaccines. Previous work from the inventors' has shown that monovalent vaccines utilizing the tumor antigens Globo H, Lewis.sup.y, GM2, glycosylated MUC-1, Tn(c), sTn(c), or TF(c) conjugated to KLH to
Throughout this application, various references are referred to. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains.
BACKGROUND OF THE INVENTION
Tumor-specific
BACKGROUND OF THE INVENTION
Tumor-specific antigens have been identified and pursued as targets for vaccines. Previous work from the inventors' has shown that monovalent vaccines utilizing the tumor antigens Globo H, Lewis.sup.y, GM2, glycosylated MUC-1, Tn(c), sTn(c), or TF(c) conjugated to KLH to
Throughout this application, various references are referred to. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains.
BACKGROUND OF THE INVENTION
Tumor-specific
Throughout this application, various references are referred to. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains.
BACKGROUND OF THE INVENTION
Tumor-specific
This invention is that of a method of detecting in a human subject the level or extent of the subject's immunity against malignant tumor occurrence or development, by (a) intradermally injecting into the subject an isotonic diagnostic solution (i) of the polysaccharide-like antigenic product